Recombinant Mouse C-type lectin domain family 12 member A(Clec12a),partial CSB-EP709488MO
Specifications
| 20ug / 100ug / 1mg price = 100ug |
Alternative Name(s):
C-type lectin-like molecule 1(CLL-1) (Myeloid inhibitory C-type lectin-like receptor) (MICL) ( Micl)
Species: (Organism)
Mus musculus (Mouse)
Gene Names:
Clec12a
Tag info:
N-terminal 10xHis-tagged and C-terminal Myc-tagged
Target Protein AA Sequence:
YTTLATEMIKSNQLQRAKEELQENVFLQLKHNLNSSKKIKNLSAMLQSTATQLCRELYSKEPEHKCKPCPKGSEWYKDSCYSQLNQYGTWQESVMACSARNASLLKVKNKDVLEFIKYKKLRYFWLALLPRKDRTQYPLSEKMFLSEESERSTDDIDKKYCGYIDRVNVYYTYCTDENNIICEETASKVQLESVLNGLPEDSR
Expression Region:
65-267aa
Subcellular Location:
Cell membrane, Single-pass type II membrane protein
Tissue Specificity:
Protein Length:
Partial
Pathway:
Mol. Weight:
30.8 kDa
Purity:
Greater than 85% as determined by SDS-PAGE.
Form:
Liquid or Lyophilized powder
Buffer:
If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Research Areas:
Others
Function:
Cell surface receptor that modulates signaling cascades and mediates tyrosine phosphorylation of target MAP kinases.
Involvement in disease:
Relevance:
Cell surface receptor that modulates signaling cascades and mediates tyrosine phosphorylation of target MAP kinases.
Reconstitution:
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Protein Families:
Reference:
"Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death." Neumann K., Castineiras-Vilarino M., Hockendorf U., Hannesschlager N., Lemeer S., Kupka D., Meyermann S., Lech M., Anders H.J., Kuster B., Busch D.H., Gewies A., Naumann R., Gross O., Ruland J. Immunity 40:389-399(2014)
